Reproductive Health & Justice Telehealth Abortion Care Access Jeopardized as Court Temporarily Reinstates In-Person Dispensing Requirement for Mifepristone May 2, 2026 Rifan Muazin The landscape of reproductive healthcare in the United States faces a significant disruption following a recent ruling by the 5th Circuit Court of Appeals, which has temporarily reinstated a requirement…
Reproductive Health & Justice FOIA Request Seeks Comprehensive Safety Data on Mifepristone from FDA April 24, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been formally submitted to the U.S. Food and Drug Administration (FDA), seeking a broad spectrum of safety data pertaining to mifepristone, a…
Reproductive Health & Justice Federal Lawmakers Mount Renewed Assault on Mifepristone Access Amidst Escalating State-Level Reproductive Rights Battles April 22, 2026 Rifan Muazin The landscape of reproductive rights in the United States is undergoing a profound and often turbulent transformation, marked by persistent federal legislative challenges and a wave of restrictive state-level actions.…
Reproductive Health & Justice FOIA Request Filed for Comprehensive Mifepristone Safety Data Amid Evolving Regulatory Scrutiny April 16, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on March 20, 2026, seeking a broad spectrum of safety data related to mifepristone, a medication widely used in medication abortion…
Reproductive Health & Justice Federal Lawmakers Target Mifepristone Amidst Escalating Reproductive Rights Battles in the U.S. April 15, 2026 Rifan Muazin Federal lawmakers are intensifying their efforts to restrict access to mifepristone, a medication widely used for abortions, while a disturbing trend of legal actions against individuals seeking reproductive healthcare continues…
Reproductive Health & Justice FOIA Request Seeks Deeper Dive into Mifepristone Safety Data from FDA April 9, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been submitted to the U.S. Food and Drug Administration (FDA) seeking comprehensive safety data related to mifepristone, a medication used in medication…
Reproductive Health & Justice Federal Lawmakers Move to Ban Mifepristone Amidst Growing Reproductive Rights Challenges Across the U.S. April 8, 2026 Rifan Muazin The landscape of reproductive rights in the United States is undergoing a significant and often contentious transformation, marked by federal legislative efforts to restrict access to medication abortion, state-level criminalization…
Reproductive Health & Justice Federal Lawmakers Seek to Ban Mifepristone Amidst Escalating State-Level Reproductive Rights Battles April 1, 2026 Rifan Muazin Federal lawmakers are intensifying their efforts to restrict access to mifepristone, a crucial medication used in medication abortions, while several states are enacting increasingly severe measures that criminalize individuals seeking…
Reproductive Health & Justice Federal Lawmakers Intensify Efforts to Restrict Mifepristone Access Amidst Growing State-Level Abortion Bans and Legal Challenges March 24, 2026 Rifan Muazin Federal lawmakers are intensifying their efforts to restrict access to mifepristone, a key medication used in medication abortions, as a patchwork of state-level abortion bans and legal challenges continues to…
